Long-term trends for socio-economic differences in prenatal diagnosis of Down syndrome: Diffusion of services or persistence of disparities?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 115, Issue 9, 2008, Pages 1087-1095

  Khoshnood, B ^a,b   De Vigan, C ^a,b   Blondel, B ^a,b   Vodovar, V ^a,b   Cadio, E ^a,b   Goffinet, F ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Down syndrome; Prenatal diagnosis; Socio economic

Indexed keywords

ARTICLE; DOWN SYNDROME; FEMALE; FRANCE; GEOGRAPHY; HEALTH SERVICE; HUMAN; OCCUPATION; POLICY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SOCIOECONOMICS; TREND STUDY;

ADULT; AFRICA; DOWN SYNDROME; EMPLOYMENT; FEMALE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MATERNAL AGE; PARIS; PREGNANCY; PRENATAL DIAGNOSIS; RESIDENCE CHARACTERISTICS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 47349095145     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.01794.x     Document Type: Article

References (42)

1. Sokal DC, Byrd JR, Chen AT, Goldberg MF, Oakley GP Jr. Prenatal chromosomal diagnosis. Racial and geographic variation for older women in Georgia. JAMA 1980 244 : 1355 7.
2. Kolker A. Advances in prenatal diagnosis. Social-psychological and policy issues. Int J Technol Assess Health Care 1989 5 : 601 17.
3. Julian-Reynier C, Macquart-Moulin G, Moatti JP, Aurran Y, Chabal F, Ayme S. Reasons for women's non-uptake of amniocentesis. Prenat Diagn 1994 14 : 859 64.
4. Halliday J, Lumley J, Watson L. Comparison of women who do and do not have amniocentesis or chorionic villus sampling. Lancet 1995 345 : 704 9.
5. Kuppermann M, Gates E, Washington AE. Racial-ethnic differences in prenatal diagnostic test use and outcomes: preferences, socioeconomics, or patient knowledge? Obstet Gynecol 1996 87 : 675 82.
6. Khoshnood B, Blondel B, De Vigan C, Bréart G. Effects of maternal age and education on the pattern of prenatal testing: implications for the use of antenatal screening as a solution to the growing number of amniocenteses. Am J Obstet Gynecol 2003 189 : 1336 42.
7. Kuppermann M, Nease RF Jr., Gates E, Learman LA, Blumberg B, Gildengorin V, et al. How do women of diverse backgrounds value prenatal testing outcomes? Prenat Diagn 2004 24 : 424 9.
8. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999 341 : 461 7.
9. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003 349 : 1405 13.
10. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005 353 : 2001 11.
11. Chilaka VN, Konje JC, Stewart CR, Narayan H, Taylor DJ. Knowledge of Down syndrome in pregnant women from different ethnic groups. Prenat Diagn 2001 21 : 159 64.
12. Khoshnood B, Blondel B, De Vigan C, Breart G. Socioeconomic barriers to informed decisionmaking regarding maternal serum screening for Down syndrome: results of the French National Perinatal Survey of 1998. Am J Public Health 2004 94 : 484 91.
13. Rowe RE, Garcia J, Davidson LL. Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the UK: a systematic review. Public Health 2004 118 : 177 89.
14. Khoshnood B, De Vigan C, Blondel B, Lhomme A, Vodovar V, Garel M, et al. Women's interpretation of an abnormal result on measurement of fetal nuchal translucency and maternal serum screening for prenatal testing of Down syndrome. Ultrasound Obstet Gynecol 2006 28 : 242 8.
15. Muggli EE, Collins VR, Halliday JL. Mapping uptake of prenatal diagnosis for Down syndrome and other chromosome abnormalities across Victoria, Australia. Aust N Z J Obstet Gynaecol 2006 46 : 492 500.
16. Muggli EE, McCloskey D, Halliday JL. Health behaviour modelling for prenatal diagnosis in Australia: a geodemographic framework for health service utilisation and policy development. BMC Health Serv Res 2006 6 : 109.
17. Khoshnood B, De Vigan C, Vodovar V, Breart G, Goffinet F, Blondel B. Advances in medical technology and creation of disparities: the case of Down syndrome. Am J Public Health 2006 96 : 2139 44.
18. Ayme S, Morichon N, Goujard J, Nisand I. Prenatal diagnosis in France. Eur J Hum Genet 1997 5 (Suppl 1 26 31.
19. De Vigan C, Vodovar V, Verite V, Dehe S, Goujard J. Current French practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97. Prenat Diagn 1999 19 : 1113 18.
20. Seror V, Costet N, Ayme S. Prenatal screening for trisomy 21 with maternal serum markers: information for decision-making in pregnant women. J Gynecol Obstet Biol Reprod (Paris) 2000 29 : 492 500.
21. Khoshnood B, De Vigan C, Vodovar V, Goujard J, Goffinet F. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. BJOG 2004 111 : 485 90.
22. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979 74 : 829 36.
23. Robbins AS, Chao SY, Fonseca VP. What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes. Ann Epidemiol 2002 12 : 452 4.
24. Walter SD. Choice of effect measure for epidemiological data. J Clin Epidemiol 2000 53 : 931 9.
25. Benn PA, Egan JF, Fang M, Smith-Bindman R. Changes in the utilization of prenatal diagnosis. Obstet Gynecol 2004 103 : 1255 60.
26. Egan JF, Benn P, Borgida AF, Rodis JF, Campbell WA, Vintzileos AM. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000 96 : 979 85.
27. Muggli EE, Halliday JL. Prenatal diagnostic testing and Down syndrome in Victoria 1992-2002. Aust N Z J Public Health 2004 28 : 465 70.
28. Resta RG. Changing demographics of advanced maternal age (AMA) and the impact on the predicted incidence of Down syndrome in the United States: implications for prenatal screening and genetic counseling. Am J Med Genet A 2005 133 : 31 6.
29. Blondel B, Supernant K, du Mazaubrun C, Bréart G. Enquête nationale périnatale 2003: situation en 2003 et évolution depuis 1998. 1 51. 2005 www.sante.gouv.fr/htm/dossiers/perinat03/enquete.pdf Accessed October 2007.
30. Marteau TM. Towards informed decisions about prenatal testing: a review. Prenat Diagn 1995 15 : 1215 26.
31. Marteau TM. Prenatal testing: towards realistic expectations of patients, providers and policy makers. Ultrasound Obstet Gynecol 2002 19 : 5 6.
32. Kuppermann M, Learman LA, Gates E, Gregorich SE, Nease RF Jr., Lewis J, et al. Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol 2006 107 : 1087 97.
33. Dolk H. EUROCAT: 25 years of European surveillance of congenital anomalies. Arch Dis Child Fetal Neonatal Ed 2005 90 : F355 8.
34. Dolk H, Loane M, Garne E, de Walle H, Queisser-Luft A, De Vigan C, et al. Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980-1999. Rev Epidemiol Sante Publique 2005 53 (Spec No 2 2S87 95.
35. EUROCAT Working Group. EUROCAT report 8: surveillance of congenital anomalies in Europe, 1980-1999. Newtownabbey, Northern Ireland : University of Ulster 2002.
36. Khoshnood B, Blondel B, Breart G, Lee KS, Pryde P, Schoendorf K. Comparison of the use of amniocentesis in two countries with different policies for prenatal testing: the case of France and the United States. Prenat Diagn 2005 25 : 14 19.
37. Blondel B, Norton J, du Mazaubrun C, Bréart G, pour la coordination nationale des enquêtes nationales périnatales. Trends in main indicators of perinatal health in France between 1995 and 1998. Results from the national perinatal surveys. J Gynecol Obstet Biol Reprod (Paris) 2001 30 : 552 64.
38. Treadwell MC. The role of informed consent in aneuploidy screening. Ultrasound Obstet Gynecol 2006 28 : 241.
39. Favre R, Duchange N, Vayssiere C, Kohler M, Bouffard N, Hunsinger MC, et al. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study. Prenat Diagn 2007 27 : 197 205.
40. Smith DK, Slack J, Shaw RW, Marteau TM. Lack of knowledge in health professionals: a barrier to providing information to patients? Qual Health Care 1994 3 : 75 8.
41. Dormandy E, Hooper R, Michie S, Marteau TM. Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit. J Med Screen 2002 9 : 109 14.
42. Cleary-Goldman J, Morgan MA, Malone FD, Robinson JN, D'Alton ME, Schulkin J. Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol 2006 107 : 11 17.